IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4)

Investigational New Drugs

Volumn 15, Issue 4, 1997, Pages 279-287

  Cai, Jie ^a   Zheng, Tong ^a   Murphy, John ^b   Waters, Cory A ^c   Lin, George Y ^a   Gill, Parkash S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Seragen Inc   (United States)

Author keywords

AIDS KS; IL 4 toxin; IL 4R

Indexed keywords

BETA ACTIN; CELL RECEPTOR; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; ONCOSTATIN M; RECOMBINANT INTERLEUKIN 4; TOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG CYTOTOXICITY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR AFFINITY; TUMOR CELL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELL DIVISION; CELLS, CULTURED; DIPHTHERIA TOXIN; HUMANS; IMMUNOTOXINS; INTERLEUKIN-4; INTERLEUKIN-6; IODINE RADIOISOTOPES; ONCOSTATIN M; PEPTIDES; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, INTERLEUKIN-4; RECOMBINANT FUSION PROTEINS; SARCOMA, KAPOSI;

EID: 0031407049     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005958123893     Document Type: Article

References (31)

1. Rutherford GW, Payne SF, Lemp GF: The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Acq Immun Defic Synd 3:S4-S7, 1990
2. Gill PS, Hamilton A, Naidu YM: Epidemic (AIDS-related) Kaposi's sarcoma: Epidemiology, pathogenesis and treatment. AIDS Updates 7:1-11, 1994
3. Gill PS, Akil B, Rarick M, Colletti P, Rarick MU, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM: Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 87:57-61, 1989
4. Jones RR, Spaull J, Spry C, Jones EW: Histogenesis of Kaposi's sarcoma in patients with and without acquired immunodeficiency syndrome. J Clin Pathol 39:742-749, 1986
5. Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill PS: The effect of interleukin-1 and IL-1 ra in AIDS-KS. J Acq Immune Defic Synd and Human Retrovir 4:455-460, 1995
6. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka S: Oncostatin-M is an autocrine growth factor in AIDS-KS. Am J Pathol 145:74-79, 1994
7. Miles SA, Rezai AR, Salazar-Gonzales JF, van der Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O: AIDS Kaposi's sarcoma-derived cells produce and respond to IL-6. Proc Natl Acad Sci USA 87:4068-4072, 1990
8. Nair BG, Devico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 25:1430-1432, 1992
9. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med 155:914-923, 1992
10. Kawakami Y, Rosenberg SA, Lotze MT: Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med 168:2183-2189, 1988
11. Noelle R, Krammer PH, Ohara J, Uhr JW, Vitetta ES: Increased expression of Ia antigens on resting B cells: An additional role for B-cell growth factor. Proc Natl Acad Sci USA 81:6149-6155, 1984
12. Tepper RI, Pattengale PK, Leder P: Murine IL-4 displays a potent anti-tumor activity in vivo. Cell 57:503-512, 1989
13. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM: Treatment of established renal cancer by tumor cells engineered to secrete IL-4. Science 254:713-716, 1991
14. Herrmann F, Andreef M, Gruss M, Brach MA, Lubbert M, Mertelsmann R: IL-4 inhibits growth of multiple myeloma by suppressing IL-6 expression. Blood 78:2070-2074, 1991
15. Hart PH, Vitti GF, Burgess DR, Whatty GA, Piccoli DS, Hamilton JA: Potential anti-inflammatory effects of IL-4: Suppression of human monocyte tumor necrosis factor alpha, IL-1, and prostaglandin E2. Proc Natl Acad Sci USA 86:3803-3807, 1989
16. Lee JD, Swisher SG, Minehart EH, McBride WH, Economou JS: IL-4 down-regulates IL-6 production in human peripheral blood mononuclear cells. J Leukocyte Biol 47:475-479, 1990
17. Idzerda RL, March CJ, Mosley B, Kyman SD, Bos VT, Gimpet SD, Din WS, Grabstein KH, Widmer MB: Human IL-4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171:861-873, 1990
18. Debinski W, Puri RK, Kreitman J, Pastan I: A wide range of human cancers express interleukin 4 (IL-4) receptors that can be targeted with chimeric toxin composed of IL-4 and Pseudomonas exotoxin. J Biol Chem 268:14065-14070, 1993
19. 389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J Biol Chem 266:21118-21124, 1991
20. Debinski W, Puri RK, Pastan I: Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin. Int J Cancer 58:744-748, 1994
21. + T cells. Science 242:426-429, 1988
22. Masood R, Husain SR, Rahman A, Gill PS: Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome encapsulated doxorubicin. AIDS Res Hum Retro 9:741-745, 1993
23. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P: Glucocorticoids enhance AIDS-related Kaposi's sarcoma growth through inhibition of TGF-β. Blood 89:1491-1500, 1997
24. Scatchard G: The attraction of proteins for small molecules and ions. Annu NY Acad Sci 51:660, 1949
25. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS: Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol 8:79-83, 1997
26. Colombatti M, Greenfield L, Youle RJ: Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry. J Biol Chem 26:3030-3035, 1986
27. Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ, Eisenberg D: The crystal structure of diphtheria toxin. Nature 357:216-222, 1992
28. Silverman JA, Mindell JA, Finkelstein A, Shen WH, Collier RJ: Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. J Biol Chem 269:22524-22532, 1994
29. Madshus IH, Wiedlocha A, Sandvig K: Intermediates in translocation of diphtheria toxin across the plasma membrane. J Biol Chem 269:4648-4652, 1994
30. 389IL-4. J Allergy Clin Immunol 95:893-900, 1995
31. Puri RK, Ogata M, Leland P, Feldman GM, Fitzgerald D, Pastan I: Expression of high-affinity IL-4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between IL-4 and Pseudomonas exotoxin. Cancer Res 51:3011-3017, 1991